CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-31 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +50,000 | $19.26 | $963K | 209,009 |
| 2025-03-31 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −162,008 | $100.22 | $16.2M | 47,001 |
| 2025-03-31 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −32,942 | $101.37 | $3.3M | 14,059 |
| 2025-03-31 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −5,050 | $102.48 | $518K | 9,009 |
| 2025-03-31 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −35,000 | 56,571 | ||
| 2025-03-31 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −75,000 | 0 | ||
| 2025-03-31 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −40,000 | 0 | ||
| 2025-03-31 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −50,000 | 50,000 | ||
| 2025-03-31 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −35,102 | $94.72 | $3.3M | 2,982,335 |
| 2025-03-24 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +421 | $13.56 | $6K | 9,430 |
| 2025-03-24 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −421 | $60.58 | $26K | 9,009 |
| 2025-03-24 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −421 | 91,571 | ||
| 2025-03-24 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −1,974 | $60.83 | $120K | 3,017,437 |
| 2025-03-24 | Maduck Sean See Remarks | Option exercise 10b5-1 | +1,697 | $5.05 | $9K | 87,319 |
| 2025-03-24 | Maduck Sean See Remarks | Sale 10b5-1 | −1,697 | $60.58 | $103K | 85,622 |
| 2025-03-24 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −1,697 | 121,986 | ||
| 2025-03-20 | Robb Gary Charles Chief Business Officer | Gift | +233 | 10,898 | ||
| 2025-03-20 | Robb Gary Charles Chief Business Officer | Gift | +233 | 10,898 | ||
| 2025-03-12 | Robb Gary Charles Chief Business Officer | Gift | −4,625 | 18,865 | ||
| 2025-03-12 | Robb Gary Charles Chief Business Officer | Gift | +1,000 | 10,665 |
Page 29 of 61 · 1,220 trades